COVID-19 and vitamin D supplementation: Is there any evidence based to reduce the risk?
Several studies and meta-analysis suggest that vitamin D deficiency constitutes a risk factor for acute respiratory infections while supplementation may reduce this risk. Given the current context of the COVID-19 pandemic, the role of vitamin D supplementation in the prevention and improvement of the prognosis of affected patients has been suggested by some studies and refuted by others. Through this article, we report the mechanisms of action and properties of vitamin D, and we discuss the different hypotheses of the involvement of vitamin D in respiratory infections, especially Covid-19 in the light of the most recent published data.
Keywords
How to Cite
Similar Articles
- Determination of the mineral profile of raw and roasted lentil flour after addition to yogurt
- Sleep quality and its relationship with climacteric symptoms and quality of life in women on menopausal transition
- Effect of traditional processing methods on protein digestibility and chemical constituents in seeds of Bauhinia petersiana
- Determinants of overweight and obesity among adolescents in Zimbabwe: A scoping review
- Talbina as a functional food and a source of health-beneficial ingredients: a narrative review
- Epidemiology, diagnosis, and assessment of diabetes mellitus in the elderly population: a purposive review
- Predictive equations overestimated the rest energy expenditure by indirect calorimetry in adults with sickle cell disease
- An overview on the incorporation of novel ingredients on nutritional, textural, and organoleptic properties of gluten-free cereal products
- A review of traditional grain-based complementary foods for children aged 6-23 months in selected African countries
- Effect of a millet-based fortified complementary food on the anthropometric and biochemical indices of anemic infants (6-24 months) - ARTICLE RETRACTED
You may also start an advanced similarity search for this article.

NAJFNR is licensed under